The Prescription Drugs (Pharmacies) market in Angola has been experiencing significant growth in recent years, driven by various factors such as changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Prescription Drugs (Pharmacies) market in Angola have shifted towards a greater demand for convenience and accessibility. Customers are increasingly looking for pharmacies that offer a wide range of prescription drugs and over-the-counter medications, as well as additional services such as health consultations and home delivery. This trend is in line with global market preferences, where customers are seeking more convenient and personalized healthcare solutions. Trends in the Prescription Drugs (Pharmacies) market in Angola include the increasing adoption of digital technologies and online platforms. Pharmacies are now leveraging technology to improve their operations, streamline processes, and enhance customer experience. Online pharmacies have gained popularity, allowing customers to order prescription drugs and have them delivered to their doorstep. This trend is driven by the growing internet penetration and smartphone usage in Angola, as well as the convenience it offers to customers. Local special circumstances in Angola, such as the high prevalence of certain diseases and limited access to healthcare facilities, have contributed to the development of the Prescription Drugs (Pharmacies) market. Angola has a high burden of diseases such as malaria, HIV/AIDS, and tuberculosis, which require regular access to prescription drugs. Pharmacies play a crucial role in providing these medications to the population, especially in remote areas where healthcare facilities are scarce. Underlying macroeconomic factors, such as the improving economy and increasing disposable income, have also contributed to the growth of the Prescription Drugs (Pharmacies) market in Angola. As the economy continues to grow, more people have the financial means to afford prescription drugs and healthcare services. This has led to an increase in demand for pharmacies and a greater willingness to spend on healthcare. In conclusion, the Prescription Drugs (Pharmacies) market in Angola is developing due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The shift towards convenience and accessibility, the adoption of digital technologies, the high burden of diseases, and the improving economy all contribute to the growth of the market. As these factors continue to evolve, the Prescription Drugs (Pharmacies) market in Angola is expected to further expand and meet the healthcare needs of the population.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
